Description: Incannex are global leaders in the development of novel medicinal cannabinoid compounds and psychedelic therapies. Incannex is a cannabinoid and psychedelic compound medicine development company undertaking six clinical programs guided by our medical advisory board.
Psychennex is pioneering the worldʼs leading Psychedelic-Assisted Psychotherapy Clinics.
World-first, Phase 2a clinical trial prioritising scientific independence and rigour for the best patient outcomes
Incannex is a global leader in the development of novel, medicinal cannabinoid compounds and psychedelic therapies.